Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.55 |
| ▸ | ACHE | P22303 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.36 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentachlorophenol SCHEMBL9707113 | 0.93 | ACHE (0.48) | TSHRACHELMNAALOX12HPGD | |
| Pentachlorophenol SCHEMBL11753576 | 0.81 | TSHR (0.77) | TSHRLMNAALOX12HPGDMEN1 | |
| Pentachlorophenol SCHEMBL4335096 | 0.79 | CA12 (0.61) | TSHRLMNAHPGDMEN1KMT2A | |
| Toluene SCHEMBL28196486 | 0.78 | ACHE (0.79) | TSHRACHELMNAALOX12HPGD | |
| Toluene SCHEMBL27883778 | 0.78 | ACHE (0.92) | TSHRACHELMNAALOX12HPGD | |
| Toluene SCHEMBL1533301 | 0.78 | — | — | |
| Toluene SCHEMBL9622812 | 0.78 | — | — | |
| Pentachlorophenol SCHEMBL11573792 | 0.75 | TSHR (0.55) | TSHRLMNAALOX12HPGDMEN1 | |
| Toluene SCHEMBL5141031 | 0.74 | — | — | |
| Toluene SCHEMBL14954006 | 0.74 | ACHE (0.85) | TSHRACHELMNAALOX12HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9617207-B2 | Method for preparation of perfluoroalkyl sulfenyl chloride | Gharda Medical and Advanced Technologies Foundation (IN) | 2017-04-11 | — | — | US | claimed |
| EP-2521712-B1 | METHOD FOR PREPARATION OF PERFLUOROMETHYLSULFENYL CHLORIDE | GHARDA KEKI HORMUSJI (IN) | 2016-12-14 | — | — | EP | claimed |
| US-20120296119-A1 | METHOD FOR PREPARATION OF PERFLUOROALKYL SULFENYL CHLORIDE | Gharda Medical and Advanced Technologies Foundation (IN) | 2012-11-22 | — | — | US | claimed |
| EP-2521712-A1 | A METHOD FOR PREPARATION OF PERFLUOROALKYL SULFENYL CHLORIDE | Gharda, Keki Hormusji (IN) | 2012-11-14 | — | — | EP | claimed |
| WO-2011080752-A1 | A METHOD FOR PREPARATION OF PERFLUOROALKYL SULFENYL CHLORIDE | GHARDA KEKI HORMUSJI (IN) | 2011-07-07 | — | — | WO | claimed |
| US-20240383886-A1 | Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof | ABBVIE INC. | 2024-11-21 | — | — | US | disclosed |
| EP-4077319-A1 | PROTEIN TYROSINE PHOSPHATASE DEGRADERS AND METHODS OF USE THEREOF | Calico Life Sciences LLC (US) | 2022-10-26 | — | — | EP | disclosed |
| WO-2021127586-A1 | PROTEIN TYROSINE PHOSPHATASE DEGRADERS AND METHODS OF USE THEREOF | CALICO LIFE SCIENCES LLC (US) | 2021-06-24 | — | — | WO | disclosed |
| CN-109689649-A | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | 百时美施贵宝公司 | 2019-04-26 | — | — | CN | disclosed |
| US-9617207-B2 | Method for preparation of perfluoroalkyl sulfenyl chloride | Gharda Medical and Advanced Technologies Foundation (IN) | 2017-04-11 | — | — | US | disclosed |
| EP-2521712-B1 | METHOD FOR PREPARATION OF PERFLUOROMETHYLSULFENYL CHLORIDE | GHARDA KEKI HORMUSJI (IN) | 2016-12-14 | — | — | EP | disclosed |
| US-20120296119-A1 | METHOD FOR PREPARATION OF PERFLUOROALKYL SULFENYL CHLORIDE | Gharda Medical and Advanced Technologies Foundation (IN) | 2012-11-22 | — | — | US | disclosed |
| EP-2521712-A1 | A METHOD FOR PREPARATION OF PERFLUOROALKYL SULFENYL CHLORIDE | Gharda, Keki Hormusji (IN) | 2012-11-14 | — | — | EP | disclosed |
| WO-2011080752-A1 | A METHOD FOR PREPARATION OF PERFLUOROALKYL SULFENYL CHLORIDE | GHARDA KEKI HORMUSJI (IN) | 2011-07-07 | — | — | WO | disclosed |
| US-20080043176-A1 | Method of Manufacturing a Polarizing Plate Protective Film, Polarizing Plate Protective Film, Polarizing Plate, and Liquid Crystal Display Device | KONICA MINOLTA OPTO, INC. (JP) | 2008-02-21 | — | — | US | disclosed |
| US-20080013173-A1 | METHOD OF MANUFACTURING A POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE | KONICA MINOLTA OPTO, INC. (JP) | 2008-01-17 | — | — | US | disclosed |
| EP-0346761-A2 | Process for the preparation of aromatic polycarbonates | BAYER AG (DE) | 1989-12-20 | — | — | EP | disclosed |
| EP-0337207-A2 | Preparation process of aromatic polycarbonates, aromatic polyestercarbonates and aromatic polyesters | BAYER AG (DE) | 1989-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120296119-A1 | METHOD FOR PREPARATION OF PERFLUOROALKYL SULFENYL CHLORIDE | PFAS, FLI1, PLTP | TSHR 26/4885ACHE 3416/4885LMNA 3290/4885 |
| US-20240383886-A1 | Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof | PTPN5, PTPN1, PTPN2 | TSHR 729/4885ACHE 4433/4885LMNA 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.